Menu
 
Research menu
Jump to menu

Publications:  Dr Jessica Okosun

Okosun J, Kridel R, Fitzgibbon J(2018). Rituximab as a first step in tackling transformation. Lancet Haematol vol. 5, (8) e326-e327.
10.1016/S2352-3026(18)30093-0
Araf S, Wang J, Ashton-Key M, Korfi K, Di Bella D, Rio-Machin A, Odabashian M, Foria V et al.(2018). Transmission of diffuse large B cell lymphoma by an allogeneic stem-cell transplant. Haematologica
10.3324/haematol.2018.196907
Heward JA, Kumar EA, Korfi K, Okosun J, Fitzgibbon J(2018). Precision medicine and lymphoma. Curr Opin Hematol vol. 25, (4) 329-334.
10.1097/MOH.0000000000000437
Araf S, Wang J, Korfi K, Pangault C, Kotsiou E, Rio-Machin A, Rahim T, Heward J et al.(2018). Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma. Leukemia vol. 32, (5) 1258-1263.
10.1038/s41375-018-0043-y
Araf S, Okosun J, Fitzgibbon J(2018). Predicting early relapse in follicular lymphoma: have we turned a corner?. Lancet Oncol vol. 19, (4) 441-442.
10.1016/S1470-2045(18)30114-1
Horton SJ, Giotopoulos G, Yun H, Vohra S, Sheppard O, Bashford-Rogers R, Rashid M, Clipson A et al. (2017). Early loss of Crebbp confers malignant stem cell properties on lymphoid progenitors. Nat Cell Biol. vol. 19, 1093-1104.
10.1038/ncb3597
Mansouri L, Noerenberg D, Young E, Mylonas E, Abdulla M, Frick M, Asmar F, Ljungström V et al.(2016). Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma. Blood vol. 128, (23) 2666-2670.
10.1182/blood-2016-03-704528
Kotsiou E, Okosun J, Besley C, Iqbal S, Matthews J, Fitzgibbon J, Gribben J, DAVIES JK(2016). TNFRSF14 aberrations in follicular lymphoma increase clinically significant allogeneic T-cell responses. Blood vol. 128, (1) 72-81.
10.1182/blood-2015-10-679191
Okosun J, Montoto S, Fitzgibbon J(2016). The routes for transformation of follicular lymphoma. Current Opinion in Hematology vol. 23, (4) 1-1.
10.1097/MOH.0000000000000255
Okosun J, Wolfson RL, Wang J, Araf S, Wilkins L, Castellano BM, Escudero-Ibarz L, Al Seraihi AF et al.(2016). Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma. Nature Genetics vol. 48, (2) 183-188.
10.1038/ng.3473
Araf S, Okosun J, Koniali L, Fitzgibbon J, Heward J(2016). Epigenetic dysregulation in follicular lymphoma. Epigenomics vol. 8, (1) 77-84.
10.2217/epi.15.96
Okosun J, Cwynarski K(2015). Non-Hodgkin Lymphoma: High Grade. Postgraduate Haematology: Seventh Edition,
Tawana K, Wang J, Renneville A, Bödör C, Hills R, Loveday C, Savic A, Van Delft FW et al.(2015). Disease evolution and outcomes in familial AML with germline CEBPA mutations. Blood vol. 126, (10) 1214-1223.
10.1182/blood-2015-05-647172
Okosun J, Packham G, Fitzgibbon J(2014). Investigational epigenetically targeted drugs in early phase trials for the treatment of haematological malignancies. Expert Opin Investig Drugs vol. 23, (10) 1321-1332.
10.1517/13543784.2014.923402
Okosun J, Bödör C, Wang J, Araf S, Yang CY, Pan C, Boller S, Cittaro D et al.(2014). Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma. Nature Genetics vol. 46, (2) 176-181.
10.1038/ng.2856
Okosun J, Bödör C, Wang J, Araf S, Yang C-Y, Pan C, Boller S, Cittaro D et al.(2014). Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma. Nat Genet vol. 46, (2) 176-181.
10.1038/ng.2856
Bödör C, Grossmann V, Popov N, Okosun J, O'Riain C, Tan K, Marzec J, Araf S et al.(2013). EZH2 mutations are frequent and represent an early event in follicular lymphoma. Blood vol. 122, (18) 3165-3168.
10.1182/blood-2013-04-496893
Montoto S, Shaw K, Okosun J, Gandhi S, Fields P, Wilson A, Shanyinde M, Cwynarski K et al.(2012). HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era. J Clin Oncol vol. 30, (33) 4111-4116.
10.1200/JCO.2011.41.4193
Okosun J, Warbey V, Shaw K, Montoto S, Fields P, Marcus R, Virchis A, McNamara C et al.(2012). Interim fluoro-2-deoxy-D-glucose-PET predicts response and progression-free survival in patients with Hodgkin lymphoma and HIV infection. AIDS vol. 26, (7) 861-865.
10.1097/QAD.0b013e32835213b1
Okosun J, Bödör C, Smith M(2011). Myelodysplastic syndrome: 2011 and beyond. Br J Nurs vol. 20, (22)
10.12968/bjon.2011.20.22.1434
Okosun J, Fitzgibbon J(2011). It's a targeted world in non-Hodgkin's lymphoma. Br J Nurs vol. 20, (17)
10.12968/bjon.2011.20.Sup10.S28
Okosun J, Fitzgibbon J(2011). It's a targeted world in non-Hodgkin's lymphoma. British Journal of Nursing vol. 20, (17 SUPPL.)
Okosun J, McNamara C(2011). Paraneoplastic peripheral blood eosinophilia in relapsed follicular lymphoma. Leuk Lymphoma vol. 52, (2) 328-330.
10.3109/10428194.2010.532891
Return to top